Skip to content

Study · Ex vivo tissue · rat · 1985

1 result

Opposing effects of oxytocin and of a mu-receptor agonistic opioid peptide on the same class of non-pyramidal neurones in rat hippocampus.

Raggenbass M, Wuarin JP, Gähwiler BH, Dreifuss JJ

Brain research1 Oct 1985Cited by 19 (Europe PMC)

PMID2994843 (opens in a new tab)DOI10.1016/0006-8993(85)90822-4 (opens in a new tab)PepBankPUB-02994843
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueMechanism

    In rat hippocampal slices uncoupled by high external magnesium, oxytocin still excited non-pyramidal neurones.

    In plain wordsIn rat brain slices where nerve cells could not signal to each other, oxytocin still excited the same nerve cells.

    Peptide
    Oxytocin
    Outcome
    IncreaseExcitation of non-pyramidal neurones under synaptic uncoupling
    Study

    ratn: not reported in source

    Hippocampal slices
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    When the slices were synaptically uncoupled by elevating the concentration of external magnesium, oxytocin still excited non-pyramidal neurones and DAGO still inhibited them.
    2 context sentences
    Summary · context
    A study was made of the effects of opioid peptides on the spontaneous firing of oxytocin-responsive non-pyramidal neurones in hippocampal slices.
    Title · context
    Opposing effects of oxytocin and of a mu-receptor agonistic opioid peptide on the same class of non-pyramidal neurones in rat hippocampus.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.